Transmission dynamics of Oropouche virus in Latin America and the Caribbean
File(s) OROV_Manaus_11.01.26_clean.docx (249.86 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Oropouche virus (OROV) is an arbovirus endemic to the Amazon region since the 1950s that re-emerged in late 2023, causing a major epidemic across Central and South America. Here we investigated the transmission dynamics of the 2023–2024 epidemic in Manaus City (Amazonas state, Brazil), a major metropolitan hub in the Amazon, and estimated OROV infections across Latin America and the Caribbean. OROV re-emergence in Manaus resulted in an increase of IgG seroprevalence from 11.4% in November 2023 to 25.7% in November 2024. The neutralizing capacity of OROV-specific IgG antibodies from individuals collected before and after the re-emergence demonstrated a median plaque reduction neutralization test 50% titer of 640 against both the historical and contemporary OROV isolates. A historical reconstruction of OROV circulation in Manaus indicated a continuous low-level transmission with two major outbreaks of comparable seasonality and magnitude in 1980–1981 and 2023–2024. We estimate approximately 336,000 OROV infections in the Amazon region under a scenario of continuous endemic transmission without major outbreaks and over 9.4 million OROV infections during major outbreaks from 1960 to 2025. Collectively, our findings provide a comprehensive assessment of OROV transmission in Manaus and contribute to a better understanding of the OROV burden.
Date Issued
2026-04-01
Date Acceptance
2026-01-13
Citation
Nature Medicine, 2026, 32 (4), pp.1383-1392
ISSN
1078-8956
Publisher
Springer Science and Business Media LLC
Start Page
1383
End Page
1392
Journal / Book Title
Nature Medicine
Volume
32
Issue
4
Copyright Statement
Copyright © The Author(s), under exclusive licence to Springer Nature America, Inc. 2026This is the author’s accepted manuscript made available under a CC-BY licence in accordance with Imperial’s Research Publications Open Access policy (www.imperial.ac.uk/oa-policy)
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/41876648
PII: 10.1038/s41591-026-04221-z
Subjects
Humans
Bunyaviridae Infections
Orthobunyavirus
Caribbean Region
Latin America
Seroepidemiologic Studies
Brazil
Antibodies, Viral
Immunoglobulin G
Male
Female
Adult
Antibodies, Neutralizing
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2026-03-24
